Brand-Herrmann Stefan-Martin, Kuznetsova Tatiana, Wiechert Andreas, Stolarz Katarzyna, Tikhonoff Valerie, Schmidt-Petersen Klaus, Telgmann Ralph, Casiglia Edoardo, Wang Ji-Guang, Thijs Lutgarde, Staessen Jan A, Brand Eva
Leibniz Institute for Arteriosclerosis Research, Department of Molecular Genetics of Cardiovascular Disease, University of Muenster, Muenster, Germany.
J Lipid Res. 2005 May;46(5):913-9. doi: 10.1194/jlr.M400405-JLR200. Epub 2005 Feb 16.
The peroxisome proliferator-activated receptor gamma (PPARgamma) Pro12Ala polymorphism affects plasma lipids, but to what extent alcohol intake interferes with this association remains unknown. We randomly recruited 251 nuclear families (433 parents and 493 offspring) in the framework of the European Project on Genes in Hypertension study and genotyped 926 participants in whom all serum lipid variables and information on alcohol consumption were available for PPARgamma2 Pro12Ala. Genotype-phenotype relations were assessed using generalized estimating equations (GEE) and a quantitative transmission disequilibrium test (QTDT). The Ala12 allele was more frequent in Novosibirsk (0.17) than in Cracow (0.12) and Mirano (0.11) (P < 0.01). Using GEE (P = 0.03) or QTDT (P = 0.007), Italian offspring carrying the Ala12 allele had higher serum HDL cholesterol than noncarriers. HDL cholesterol levels were on average 0.086 mmol/l (P = 0.001) higher in drinkers than in nondrinkers. Compared with Pro12 homozygotes, Ala12 allele carriers consuming alcohol had higher serum total and HDL cholesterol, with the opposite trend occurring in nondrinkers. This genotype-alcohol interaction was independent of the type of alcoholic beverage and more pronounced in moderate than in heavy drinkers. We conclude that alcohol intake modulates the relation between the PPARgamma2 Pro12Ala and HDL cholesterol level and that, therefore, the Pro12Ala polymorphism, pending confirmation of our findings, might affect cardiovascular prognosis.
过氧化物酶体增殖物激活受体γ(PPARγ)Pro12Ala多态性会影响血脂,但酒精摄入对这种关联的干扰程度尚不清楚。在欧洲高血压基因项目研究框架内,我们随机招募了251个核心家庭(433名父母和493名后代),对926名参与者进行基因分型,这些参与者均有关于PPARγ2 Pro12Ala的所有血清脂质变量和酒精消费信息。使用广义估计方程(GEE)和定量传递不平衡检验(QTDT)评估基因型与表型的关系。Ala12等位基因在新西伯利亚的频率(0.17)高于克拉科夫(0.12)和米拉诺(0.11)(P<0.01)。使用GEE(P = 0.03)或QTDT(P = 0.007),携带Ala12等位基因的意大利后代血清高密度脂蛋白胆固醇高于非携带者。饮酒者的高密度脂蛋白胆固醇水平平均比不饮酒者高0.086 mmol/l(P = 0.001)。与Pro12纯合子相比,饮酒的Ala12等位基因携带者血清总胆固醇和高密度脂蛋白胆固醇更高,而不饮酒者则呈现相反趋势。这种基因型与酒精的相互作用与酒精饮料类型无关,在中度饮酒者中比在重度饮酒者中更明显。我们得出结论,酒精摄入调节了PPARγ2 Pro12Ala与高密度脂蛋白胆固醇水平之间的关系,因此,在我们的研究结果得到证实之前,Pro12Ala多态性可能会影响心血管预后。